Targeting Hsp90 in Non-Cancerous Maladies

Area of Science:

• Molecular biology
• Oncology
• Infectious diseases

Background:

• Heat shock protein-90 (Hsp90) is a molecular chaperone essential for the stability and function of numerous client proteins, including those driving cancer.
• Hsp90's ATPase activity is vital for its chaperone function, making it a key target for cancer therapeutics.
• Pathogens exploit host Hsp90 for their propagation, highlighting its role in infectious diseases.

Purpose of the Study:

• To review the structure and function of Hsp90 in both hosts and pathogens.
• To explore the role of Hsp90 in viral and parasitic diseases.
• To discuss the therapeutic potential of Hsp90 inhibitors in cancer and infectious diseases.

Main Methods:

• Literature review of Hsp90 structure and function.
• Analysis of Hsp90's role in cancer pathogenesis.
• Examination of Hsp90's involvement in pathogen propagation.
• Evaluation of Hsp90 inhibitors as therapeutic agents.

Main Results:

• Hsp90 is critical for tumor initiation, progression, and metastasis.
• Hsp90 inhibitors targeting ATPase activity show promise for cancer therapy.
• Pathogens utilize host Hsp90 for replication, presenting a target for anti-infective strategies.
• Post-translational modifications and co-chaperones offer secondary inhibition targets.

Conclusions:

• Hsp90 is a validated target for cancer therapy.
• Hsp90 inhibitors represent a potential treatment modality for viral and parasitic infections.
• Combination therapies involving Hsp90 inhibitors and disease-specific agents may enhance treatment efficacy.